CA Life Sciences Assn.Tackling Emerging Viruses: CLSA Q&A with PaxVax CEO Nima FarzanIn recent years, a new round of terrifying viruses has captured the public’s imagination. Ebola, H1N1, SARS, Zika and other pathogens…Jul 14, 2016Jul 14, 2016
CA Life Sciences Assn.Dana Goldman Q&A with CLSA: The Downside of Price ControlsOngoing drug pricing controversies have spurred a larger discussion about using cost controls to make medicines more accessible. Recently…Feb 18, 2016Feb 18, 2016